RxDoctor Payments Data

Joseph Walsh, PA

Physician Assistant · Honolulu, HINPI 1508470923

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Viiv Healthcare Company at 29.2% of the total. Reporting peaked in 2022 at $859 and has fallen 53.2% since, to $402 in 2024.

$2,219in general payments, 2019–2025

Across 76 payments — averaging $29.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$647
  • Gilead$345
  • Indivior Inc.$328
  • AbbVie$258
  • Merck$201
  • Teleflex LLC$132
  • plus $307 from 5 others

What the payments were for

  • Food & beverage$2,219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,219 in reported general payments places this provider in the 80th percentile of 246 physician assistant providers in Hawaii.

See all physician assistant providers in Hawaii

Medicare billing

Part B allowed, 2024
$4,070
Medicare patients
35
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide25$29,168
JardianceEmpagliflozin11$16,126
Advair HfaFluticasone Propion/Salmeterol14$3,874
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,544
Atorvastatin Calcium97$1,521
Testosterone11$1,262
Tamsulosin Hcl30$560
Albuterol Sulfate HfaAlbuterol Sulfate25$460
Omeprazole21$384
Rosuvastatin Calcium15$365
Amlodipine Besylate39$313
Metformin Hcl39$303
Fluticasone Propionate16$278
Losartan Potassium34$274
Metoprolol Succinate22$272

Paid to pharmacies, not to this prescriber.

Other physician assistant in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →